Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus

NCT01191320 ↗

Phase 2 Completed 102 enrolled Repros Therapeutics Inc.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the effect the investigative drug has on glycemic control in men with type 2 diabetes mellitus (T2DM) and secondary hypogonadism

Timeline

Start: 2010-10
Primary completion: 2011-12
Completion: 2011-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Androxal	Unknown	12.5 mg	—
Subject	Androxal	Unknown	25 mg	—

Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus

Summary

Timeline

Drugs

Indications